2-5A synthetase activities in herpes virus infection and after interferon treatment.
D015088:2',5'-Oligoadenylate Synthetase / Q000378:metabolism*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002283:Carcinoma, Bronchogenic / Q000201:enzymology / Q000628:therapy; D005260:Female; D006562:Herpes Zoster / Q000201:enzymology* / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D007962:Leukocytes / Q000201:enzymology; D008223:Lymphoma / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use*; D013997:Time Factors
D007370:Interferon Type I; D011994:Recombinant Proteins; D015088:2',5'-Oligoadenylate Synthetase